Moore Alison (CIK 0001754937)

Latest company ownership

Role: Chief Technical Officer
Shares held
500,000
Last filed at
Nov 17, 2025
Confidence Score
47.2
2025Q4
Confidence Score History
2025Q4 2025Q4
Role: Chief Technical Officer
Shares held
432,738
Last filed at
Mar 24, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 13, 2025 Oct 15, 2025 CODEXIS, INC. Chief Technical Officer Sell 46.3 -6,239 -3.55% $15.6K
Mar 14, 2023 Mar 16, 2023 Allogene Therapeutics, Inc. Chief Technical Officer Sell 46.3 -8,351 -6.79% $46K
Mar 15, 2022 Mar 17, 2022 Allogene Therapeutics, Inc. Chief Technical Officer Sell 42.5 -8,698 -6.74% $66.4K
Mar 15, 2021 Mar 17, 2021 Allogene Therapeutics, Inc. Chief Technical Officer Sell 42.5 -6,164 -5.67% $235.1K
Oct 12, 2020 Oct 13, 2020 Allogene Therapeutics, Inc. Chief Technical Officer Sell 20.0 -35,264 -13.99% $1.5M
Oct 8, 2020 Oct 9, 2020 Allogene Therapeutics, Inc. Chief Technical Officer Sell 15.0 -44,574 -16.47% $1.8M
Oct 6, 2020 Oct 8, 2020 Allogene Therapeutics, Inc. Chief Technical Officer Sell 5.0 -44,574 -27.47% $1.8M
Mar 16, 2020 Mar 18, 2020 Allogene Therapeutics, Inc. Chief Technical Officer Sell 42.5 -3,750 -5.62% $72K
Sep 16, 2019 Sep 18, 2019 Allogene Therapeutics, Inc. Chief Technical Officer Sell 15.0 -48,827 -19.77% $1.6M
Jul 26, 2019 Jul 30, 2019 Allogene Therapeutics, Inc. Chief Technical Officer Sell 15.0 -48,827 -19.93% $1.4M
Jun 3, 2019 Jun 5, 2019 Allogene Therapeutics, Inc. Chief Technical Officer Sell 5.0 -48,828 -56.52% $1.3M